Two more drugs for dyslipidemia.
作者信息
Roberts William Clifford
出版信息
Am J Cardiol. 2004 Mar 15;93(6):809-11. doi: 10.1016/j.amjcard.2004.01.022.
Abstract
摘要
相似文献
1
Two more drugs for dyslipidemia.
Am J Cardiol. 2004 Mar 15;93(6):809-11. doi: 10.1016/j.amjcard.2004.01.022.
2
Public health. U.S. panel favors wider use of preventive drug treatment.
Science. 2010 Jan 8;327(5962):130-1. doi: 10.1126/science.327.5962.130.
3
Complications and side effects. Crestor tested in PHAs.
TreatmentUpdate. 2005 Jun-Jul;17(4):6-7.
4
Rosuvastatin: winner in the statin wars, patients' health notwithstanding.
BMJ. 2015 Mar 17;350:h1388. doi: 10.1136/bmj.h1388.
5
The statin wars.
Lancet. 2003 Nov 1;362(9394):1498. doi: 10.1016/S0140-6736(03)14698-3.
6
New drug to lower cholesterol.
FDA Consum. 2003 Nov-Dec;37(6):3.
7
Rosuvastatin receives FDA approval.
Cardiovasc J S Afr. 2003 Sep-Oct;14(5):286.
8
The stain wars.
Lancet. 2003 Nov 29;362(9398):1855-6; discussion 1856. doi: 10.1016/s0140-6736(03)14934-3.
9
[By JUPITER! Disease mongering!].
Lakartidningen. 2008 Dec 17;105(51-52):3756; discussion 3756-7.
10
The stain wars.
Lancet. 2003 Nov 29;362(9398):1854; discussion 1856. doi: 10.1016/s0140-6736(03)14909-4.
Zotero 插件